Stimulant ADHD medication and risk for substance abuse-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Stimulant ADHD medication and risk for substance abuse

Published:2013-10-25 Issue:8 Volume:55 Page:878-885
ISSN:0021-9630
Container-title:Journal of Child Psychology and Psychiatry
language:en
Short-container-title:J Child Psychol Psychiatr

Author:

Chang Zheng¹,Lichtenstein Paul¹,Halldner Linda¹²,D'Onofrio Brian³,Serlachius Eva⁴,Fazel Seena⁵,Långström Niklas¹,Larsson Henrik¹

Affiliation:

1. Department of Medical Epidemiology and Biostatistics; Karolinska Institutet; Stockholm Sweden

2. Karolinska Institutet Center of Neurodevelopmental Disorders (KIND); Stockholm Sweden

3. Department of Psychological and Brain Sciences; Indiana University; Bloomington IN USA

4. Department of Clinical Neuroscience; Centre for Psychiatric Research and Education; Karolinska Institutet; Stockholm Sweden

5. Department of Psychiatry; University of Oxford; Oxford UK

Funder

Swedish Research Council

Swedish Council for Working Life and Social Research

Swedish Prison and Probation Services

National Institute of Child Health and Human Development

Wellcome Trust

Publisher

Wiley

Subject

Psychiatry and Mental health,Developmental and Educational Psychology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jcpp.12164/fullpdf

Reference41 articles.

1. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, double-blind, parallel group, dose-escalation study;Adler;Journal of Clinical Psychopharmacology,2009

2. Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline;Banaschewski;European Child & Adolescent Psychiatry,2006

3. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study;Barkley;Pediatrics,2003

4. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: A naturalistic controlled 10-year follow-up study;Biederman;The American Journal of Psychiatry,2008

5. Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?;Boileau;The Journal of Neuroscience: the Official Journal of the Society for Neuroscience,2008

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risques du méthylphénidate au long cours;Annales Médico-psychologiques, revue psychiatrique;2024-09

2. Wider health needs in attention deficit hyperactivity disorder from lived and professional experience: a qualitative framework analysis;BMJ Open;2024-08

3. Attention-deficit/hyperactivity disorder is associated with more alcohol problems and less substance-free reinforcement: A behavioral economics daily diary study of college student drinkers.;Psychology of Addictive Behaviors;2024-06

4. Attention-deficit/hyperactivity disorder combined subtype exacerbates opioid use disorder consequences: Mediation by impulsive phenotypes;Drug and Alcohol Dependence;2024-06

5. Impact of Treatment with Central Nervous System Stimulant and Risk of Substance Use Disorder in Adults with Attention-Deficit/Hyperactivity Disorder;International Journal of Mental Health and Addiction;2024-05-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3